Pramipexole Dihydrochloride Tablet, Extended Release
Product Images NDC 16714-919

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Pramipexole Dihydrochloride (NDC 16714-919). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pramipexole 0 375mg 30s

Label for Pramipexole Dihydrochloride Extended-Release Tablets, 0.375 mg strength, oral dosage form. The label indicates a 30-tablet package from NorthStar Rx LLC. It includes dosage instructions emphasizing swallowing whole without chewing, storage conditions, and manufacturer information for NorthStar Rx LLC and Macleods Pharmaceuticals Ltd.*

FDA Label Image

Pramipexole 0 75mg 30s

Label for Pramipexole Dihydrochloride Extended-Release Tablets 0.75 mg, oral dosage form, once daily. The label indicates the package contains 30 tablets in an original unit of use container. It includes storage instructions, manufacturer details (NorthStar Rx LLC and Macleods Pharmaceuticals Ltd., India), and NDC 16714-917-01.*

FDA Label Image

Pramipexole 1 5mg 30s

Label for Pramipexole Dihydrochloride Extended-Release Tablets 1.5 mg, oral dosage form, once daily. The label indicates a 30-tablet count in the original unit of use container. It includes dosage and storage instructions, manufacturer information for NorthStar Rx LLC in Memphis, TN, and Macleods Pharmaceuticals Ltd., Baddi, India, with a revision date of 08/2020.*

FDA Label Image

Pramipexole 2 25mg 30s

Pramipexole Dihydrochloride Extended-Release Tablets 2.25 mg in a 30 tablet unit use container, labeled for once daily oral dosing. The label includes NDC 16714-919-01 and states it is manufactured by Macleods Pharmaceuticals Ltd., India, for Northstar Rx LLC. Dosage and storage instructions are also visible.*

FDA Label Image

Pramipexole 3 75mg 30s

Label for Pramipexole Dihydrochloride Extended-Release Tablets 3.75 mg, oral dosage form, once daily. The label shows it contains 30 tablets in the original unit of use container. The product is manufactured for NorthStar Rx LLC and by Macleods Pharmaceuticals Ltd., India. The label includes storage instructions, dosing notes, barcodes, and a NDC number 16714-921-01.*

FDA Label Image

Pramipexole 3mg 30s

Label for Pramipexole Dihydrochloride Extended-Release Tablets, 3 mg strength, in a package of 30 tablets. The label includes dosing warnings, storage instructions, and manufacturer details. It indicates tablets are to be swallowed whole and not chewed, crushed, or divided. Manufactured for NorthStar Rx LLC and by Macleods Pharmaceuticals Ltd., India.*

FDA Label Image

Pramipexole 4 5mg 30s

Label for Pramipexole Dihydrochloride Extended-Release Tablets, 4.5 mg strength, oral dosage form. The label indicates a 30-tablet unit of use container and is marked for prescription use only. Manufactured for NorthStar Rx LLC and by Macleods Pharmaceuticals Ltd in India, the label includes dosing and storage instructions, emphasizing that tablets should be swallowed whole. The NDC code is 16714-922-01.*

FDA Label Image

Prami (Pramipexole Structural Formula)

Chemical structure of Pramipexole Dihydrochloride, showing the molecular arrangement including a bicyclic system with nitrogen and sulfur atoms, and associated with two hydrochloride and one water molecules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.